Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Investigative Dermatology Année : 2021

Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations

(1) , (2) , (1) , (1) , (3) , (4, 5) , (2) , (1) , (1) , (6) , (7) , (1, 8)
1
2
3
4
5
6
7
8
Jean-David Bouaziz
Eric Fontas
Pascal Reygagne

Dates et versions

hal-03338969 , version 1 (09-09-2021)

Identifiants

Citer

Florence Le Duff, Jean-David Bouaziz, Eric Fontas, Michel Ticchioni, Manuelle Viguier, et al.. Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations. Journal of Investigative Dermatology, 2021, 141 (4), pp.933-936.e6. ⟨10.1016/j.jid.2020.08.015⟩. ⟨hal-03338969⟩
22 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More